SEC 13F Intelligence

Octagon Capital Advisors LP / OCUL

Octagon Capital Advisors LP’s Ocular Therapeutix Inc Position

Does Octagon Capital Advisors LP own Ocular Therapeutix Inc (OCUL)? Yes — 3.17M shares worth $27M (+2.97% of its 13F portfolio) as of Q1 2026, up from 2.62M shares the prior filed quarter.

Position Value
$27M
Q1 2026
Shares
3.17M
% of Portfolio
+2.97%
Quarters Held
9
currently held

Position History OCUL

Reported value by quarter
Q1 ’24: $22MQ1 ’24Q2 ’24: $17MQ3 ’24: $21MQ3 ’24Q4 ’24: $21MQ1 ’25: $18MQ1 ’25Q2 ’25: $23MQ3 ’25: $31MQ3 ’25Q4 ’25: $32MQ1 ’26: $27MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.17M$27M+2.97%
Q4 20252.62M$32M+3.87%
Q3 20252.62M$31M+4.65%
Q2 20252.42M$23M+4.94%
Q1 20252.42M$18M+3.44%
Q4 20242.42M$21M+3.41%
Q3 20242.42M$21M+3.28%
Q2 20242.42M$17M+2.61%
Q1 20242.42M$22M+2.64%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of OCUL.